Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05602779 · ClinicalTrials.gov registry record · NA
Leverage Noninvasive Transcutaneous Vagus Nerve Stimulation to Reduce Suicidal Behaviors in Vulnerable Adolescents
A NA study of Suicidal Ideation and Self Harm, sponsored by University of Notre Dame.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT05602779 is a NA study of Suicidal Ideation and Self Harm that is actively recruiting participants, run by University of Notre Dame. The registered enrollment target is 200 participants, below the 266-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (25% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05602779, a NA study of Suicidal Ideation and Self Harm, is actively recruiting participants, sponsored by University of Notre Dame.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
Suicidal thoughts, suicide attempts, and suicide are increasingly common in adolescence. Current face-to-face prevention approaches are of limited effectiveness, rely on extensive resources, and are at odds with adolescents' digital preferences. We will evaluate two unconventional but promising interventions delivered to 13- to 17-year-olds: transcutaneous vagus nerve stimulation to target emotion dysregulation, and a peer-support smartphone app to combat social isolation. If effective, these digitally-delivered interventions could reach far more adolescents at far lower cost than current approaches.
Conditions Studied
Interventions
- DEVICE tVNS Program
- OTHER Phone App Program
- COMBINATION_PRODUCT tVNS and Phone App Program
- OTHER Sham tNVS and Control App
Study Locations (2)
Indiana
- University of Notre Dame - South Bend
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-11-15 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05602779
The ClinicalTrials.gov registry entry for NCT05602779 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (25% lower). The listed sponsor is University of Notre Dame, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 4 interventions - of which tVNS Program is the first listed.
NCT05602779 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, New York.
Frequently Asked Questions
What is clinical trial NCT05602779 about?
NCT05602779 is a clinical study titled "Leverage Noninvasive Transcutaneous Vagus Nerve Stimulation to Reduce Suicidal Behaviors in Vulnerable Adolescents". Suicidal thoughts, suicide attempts, and suicide are increasingly common in adolescence. Current face-to-face prevention approaches are of limited effectiveness, rely on extensive resources, and are at odds with adolescents' digital preferences. We will evaluate two unconventional but promising int...
What is the current status of trial NCT05602779?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-11-15. Estimated completion is 2027-09-30.
What conditions does trial NCT05602779 study?
This clinical trial studies the following conditions: Suicidal Ideation, Self Harm.
What interventions are being tested in trial NCT05602779?
The interventions under investigation include: tVNS Program (DEVICE), Phone App Program (OTHER), tVNS and Phone App Program (COMBINATION_PRODUCT), Sham tNVS and Control App (OTHER).
Who is sponsoring clinical trial NCT05602779?
This trial is sponsored by University of Notre Dame, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05602779 being conducted?
This trial has 2 study locations across Indiana, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.